The Lancet Neurology
Fecha de publicación: 17 January 2020
DOI: https://doi.org/10.1016/S1474-4422(19)30368-0
Autores: Prof Frank Jessen, MD., Rebecca E Amariglio, PhD., Rachel F Buckley, PhD., Wiesje M van der Flier, PhD., Ying Han, MD., José Luis Molinuevo, MD., et al.
Background: A growing awareness about brain health and Alzheimer’s disease in the general population is leading to an increasing number of cognitively unimpaired individuals, who are concerned that they have reduced cognitive function, to approach the medical system for help. The term subjective cognitive decline (SCD) was conceived in 2014 to describe this condition.
